Literature DB >> 10934089

Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P).

R Lazor1, A Vandevenne, A Pelletier, P Leclerc, I Court-Fortune, J F Cordier.   

Abstract

Cryptogenic organizing pneumonia (COP) is a clinicopathologic syndrome characterized by rapid resolution with corticosteroids, but frequent relapses when treatment is tapered or stopped. We retrospectively studied relapses in 48 cases of biopsy-proven COP. One or more relapses (mean 2.4 +/- 2.2) occurred in 58%. At first relapse, 68% of patients were still under treatment for the initial episode. Compared with the no-relapse group, nine patients with multiple (>/= 3) relapses had longer delays between first symptoms and treatment onset (22 +/- 17 versus 11 +/- 8 wk, p = 0.02), and elevated gamma-glutamyltransferase (124 +/- 98 versus 29 +/- 13 IU/L, p = 0.001) and alkaline phosphatase (190 +/- 124 versus 110 +/- 68 IU/L, p = 0.04) levels. Relapses did not adversely affect outcome. Corticosteroid treatment side effects occurred in 25% of patients. Standardized treatment in 14 patients allowed a reduction of prednisone cumulated doses (p < 0.05) without affecting outcome or relapse rate. We conclude that: (1) delayed treatment increases the risk of relapses; (2) mild cholestasis identifies a subgroup of patients with multiple relapses; (3) relapses do not affect outcome, and prolonged therapy to suppress relapses appears unnecessary; (4) a standardized treatment allows a reduction in steroid doses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934089     DOI: 10.1164/ajrccm.162.2.9909015

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  45 in total

Review 1.  Systematic review of postradiotherapy bronchiolitis obliterans organizing pneumonia in women with breast cancer.

Authors:  Gary R Epler; Eileen M Kelly
Journal:  Oncologist       Date:  2014-10-31

Review 2.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Chronic panuveitis and scleritis in a patient with cryptogenic organizing pneumonia.

Authors:  Wataru Saito; Akari Saito; Kenichi Namba; Satoru Kase; Masanori Shiratori; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2006 Nov-Dec       Impact factor: 2.447

Review 4.  [Idiopathic interstitial pneumonias: from classification to diagnostic work-up].

Authors:  C Müller-Mang; L Stiebellehner; K Schmid; A Bankier
Journal:  Radiologe       Date:  2007-05       Impact factor: 0.635

5.  Predictors of Relapse in Patients with Organizing Pneumonia.

Authors:  Minjung Kim; Seung-Ick Cha; Hyewon Seo; Kyung-Min Shin; Jae-Kwang Lim; Hyera Kim; Seung-Soo Yoo; Jaehee Lee; Shin-Yup Lee; Chang-Ho Kim; Jae-Yong Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-06-30

Review 6.  Organizing pneumonia: a kaleidoscope of concepts and morphologies.

Authors:  Benjamin J Roberton; David M Hansell
Journal:  Eur Radiol       Date:  2011-07-10       Impact factor: 5.315

7.  Intravenous immune globulins (IVIg) treatment for organizing pneumonia in a selective IgG immune deficiency state.

Authors:  Itai Gueta; Yehuda Shoenfeld; Hedi Orbach
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

8.  Organizing pneumonia and occupational and environmental risk factors: a case-control study.

Authors:  Stéphanie Jobard; Benjamin Chaigne; Sylvain Marchand-Adam; Gérard Lasfargues; Elisabeth Diot
Journal:  Int Arch Occup Environ Health       Date:  2017-08-01       Impact factor: 3.015

9.  Organizing pneumonia revisited: insights and uncertainties from a series of 67 patients.

Authors:  A L Vieira; A Vale; N Melo; P Caetano Mota; J M Jesus; R Cunha; S Guimarães; C Souto Moura; A Morais
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

10.  A 12-week combination of clarithromycin and prednisone compared to a 24-week prednisone alone treatment in cryptogenic and radiation-induced organizing pneumonia.

Authors:  Nicolas Petitpierre; Vincent Cottin; Sylvain Marchand-Adam; Sandrine Hirschi; Dominique Rigaud; Isabelle Court-Fortune; Stéphane Jouneau; Dominique Israël-Biet; Anita Molard; Jean-François Cordier; Romain Lazor
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.